Nuclear export in non-hodgkin lymphoma and implications for targeted xpo1 inhibitors

HIGHLIGHTS

• who: Kyla L. Trkulja et al. from the Institute of Medical Science, University of Toronto, King`s College Circle, Toronto, ON M S , Canada have published the research work: Nuclear Export in Non-Hodgkin Lymphoma and Implications for Targeted XPO1 Inhibitors, in the Journal: Biomolecules 2023, 13, 111. of /2023/
• what: The authors then highlight the research to date on XPO1 such as selinexor and other selective of export (SINEs) which are used to treat some cases of non-Hodgkin lymphoma.
• future: Future research should investigate the role of XPO1-mediated miRNA export . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.